Adam R Craig Selected Research

vosaroxin

11/2018	Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia.
9/2015	Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
2/2015	A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam R Craig Research Topics

Disease

3	Thrombocytopenia (Thrombopenia) 01/2022 - 09/2012
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 11/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018 - 02/2015
2	Neutropenia 09/2015 - 09/2012
2	Stomatitis 09/2015 - 02/2015
1	Hemorrhage 01/2022
1	Febrile Neutropenia 09/2015
1	Pneumonia (Pneumonitis) 09/2015
1	Sepsis (Septicemia) 09/2015
1	Anemia 09/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2012
1	Leukemia 12/2003

Drug/Important Bio-Agent (IBA)

3	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2018 - 02/2015
3	vosaroxinIBA 11/2018 - 02/2015
2	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2022 - 11/2020
2	ruxolitinibIBA 01/2022 - 11/2020
1	Janus KinasesIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	fedratinibIBA 01/2022
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2022
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2015
1	QuinolonesIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Tyrosine Kinase InhibitorsIBA 09/2012
1	Clofarabine (Clolar)FDA Link 12/2003

Therapy/Procedure

1	Drug Tapering 09/2012
1	Therapeutics 09/2012